Works matching IS 10870156 AND DT 2020 AND VI 38 AND IP 5
Results: 35
Publisher Correction: γδ T cells bring unconventional cancer-targeting to the clinic — again.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Drug-induced protein degradation heats up.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 514, doi. 10.1038/s41587-020-0529-9
- Publication type:
- Article
Around the world in a month.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 518, doi. 10.1038/s41587-020-0524-1
- Publication type:
- Article
Epigenetic drugs.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 558, doi. 10.1038/s41587-020-0523-2
- Publication type:
- Article
Fast, portable tests come online to curb coronavirus pandemic.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 515, doi. 10.1038/d41587-020-00010-2
- By:
- Publication type:
- Article
Biggest COVID-19 trial tests repurposed drugs first.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 510, doi. 10.1038/s41587-020-0528-x
- Publication type:
- Article
The pandemic pipeline.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 523, doi. 10.1038/d41587-020-00005-z
- By:
- Publication type:
- Article
All that's fit to preprint.
- Published in:
- 2020
- Publication type:
- Editorial
First drug approved for neurofibromas is a MEK inhibitor.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 513, doi. 10.1038/s41587-020-0530-3
- Publication type:
- Article
People.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 652, doi. 10.1038/s41587-020-0522-3
- Publication type:
- Article
Active machine learning helps drug hunters tackle biology.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 512, doi. 10.1038/s41587-020-0521-4
- By:
- Publication type:
- Article
Cancer-eating immune cells kitted out with CARs.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 509, doi. 10.1038/s41587-020-0520-5
- By:
- Publication type:
- Article
Access and benefit-sharing following the synthesis of horsepox virus.
- Published in:
- 2020
- By:
- Publication type:
- Letter
1Q20 — biotech stocks nosedive.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 521, doi. 10.1038/s41587-020-0516-1
- By:
- Publication type:
- Article
First-quarter biotech job picture.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 651, doi. 10.1038/s41587-020-0515-2
- By:
- Publication type:
- Article
Drug pipeline 1Q20.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 519, doi. 10.1038/s41587-020-0514-3
- By:
- Publication type:
- Article
Developing therapeutic monoclonal antibodies at pandemic pace.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 540, doi. 10.1038/s41587-020-0512-5
- By:
- Publication type:
- Article
Viral contamination in biologic manufacture and implications for emerging therapies.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 563, doi. 10.1038/s41587-020-0507-2
- By:
- Publication type:
- Article
Diamonds in the doublets.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 559, doi. 10.1038/s41587-020-0511-6
- By:
- Publication type:
- Article
Publisher Correction: Single-cell RNA-seq analysis software providers scramble to offer solutions.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Nature Biotechnology's academic spinouts of 2019.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 546, doi. 10.1038/s41587-020-0506-3
- By:
- Publication type:
- Article
Adapting the ordre public and morality exclusion of European patent law to accommodate emerging technologies.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 555, doi. 10.1038/s41587-020-0504-5
- By:
- Publication type:
- Article
Publisher Correction: Engineering bacterial symbionts of nematodes improves their biocontrol potential to counter the western corn rootworm.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Author Correction: Reply to: Fitness effects of CRISPR/Cas9-targeting of long noncoding RNA genes.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
In conversation with four startup CEOs.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 533, doi. 10.1038/s41587-020-0498-z
- By:
- Publication type:
- Article
Multiplex digital spatial profiling of proteins and RNA in fixed tissue.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 586, doi. 10.1038/s41587-020-0472-9
- By:
- Publication type:
- Article
Prime genome editing in rice and wheat.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 582, doi. 10.1038/s41587-020-0455-x
- By:
- Publication type:
- Article
Superior field performance of waxy corn engineered using CRISPR–Cas9.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 579, doi. 10.1038/s41587-020-0444-0
- By:
- Publication type:
- Article
Dissecting cellular crosstalk by sequencing physically interacting cells.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 629, doi. 10.1038/s41587-020-0442-2
- By:
- Publication type:
- Article
Massively parallel interrogation and mining of natively paired human TCRαβ repertoires.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 609, doi. 10.1038/s41587-020-0438-y
- By:
- Publication type:
- Article
Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9–Cas12a platform.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 638, doi. 10.1038/s41587-020-0437-z
- By:
- Publication type:
- Article
Reply to: Fitness effects of CRISPR/Cas9-targeting of long noncoding RNA genes.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Engineering bacterial symbionts of nematodes improves their biocontrol potential to counter the western corn rootworm.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 600, doi. 10.1038/s41587-020-0419-1
- By:
- Publication type:
- Article
Fitness effects of CRISPR/Cas9-targeting of long noncoding RNA genes.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 5, p. 620, doi. 10.1038/s41587-020-0414-6
- By:
- Publication type:
- Article